healthy adult
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Voluntary, non-remunerated, healthy donors who have donated bone marrow etc. 2)Individuals capable of giving voluntary, informed consent in writing
Exclusion criteria
Exclusion criteria: 1)Enrolling related studies of generating iPSC banks 2)The following viral infection: Hepatic Virus B Hepatic Virus C Human Immunodeficiency Virus Human T-cell leukemia virus Human parvovirus B19 Cytomegalovirus 3)The following microbial infection: Treponema pallidum West Nile Virus Chlamydiaceae Genus Neisseria Mycobacterium Malaria parasites(Plasmodium spp.) Babesia Trypanosoma cruzi Leishmania Trypanosoma brucei 4)Malignant neoplasm 5)Transmissible spongiform encephalopathy (including suspected case), Dementia or cognitive impairment, Stroke, Seizure 6)The following conditions: Particular or genetic/hereditary disorders Severe or uncontrolled metabolic or endocrinal disorders Connective tissue diseases Severe or uncontrolled hematologic diseases Severe or uncontrolled hepatic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Charactrization of iPS cells derived from HLA homozyougous donor. | — |
Countries
Japan
Contacts
Center for iPS Cell Research and Application (CiRA), Kyoto University Medical Application Promotion Office